These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26448459)

  • 1. Homoharringtonine binds to and increases myosin-9 in myeloid leukaemia.
    Zhang T; Shen S; Zhu Z; Lu S; Yin X; Zheng J; Jin J
    Br J Pharmacol; 2016 Jan; 173(1):212-21. PubMed ID: 26448459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC analysis of harringtonine and homoharringtonine in the needles of Cephalotaxus griffithii alkaloid fraction and cytotoxic activity on chronic myelogenous leukaemia K562 cell.
    Moirangthem DS; Borah JC; Laishram S; Kalita MC; Talukdar NC
    Nat Prod Res; 2014; 28(18):1503-6. PubMed ID: 24787645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1.
    Zhou M; Zeng J; Wang X; Guo Q; Huang T; Shen H; Fu Y; Wang L; Jia J; Chen C
    J Transl Med; 2013 Oct; 11():265. PubMed ID: 24148180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells.
    Chen J; Mu Q; Li X; Yin X; Yu M; Jin J; Li C; Zhou Y; Zhou J; Suo S; Lu D; Jin J
    Oncotarget; 2017 Jun; 8(25):40318-40326. PubMed ID: 28454099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
    Visani G; Russo D; Ottaviani E; Tosi P; Damiani D; Michelutti A; Manfroi S; Baccarani M; Tura S
    Leukemia; 1997 May; 11(5):624-8. PubMed ID: 9180282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines.
    Wang Q; Ding W; Ding Y; Ma J; Qian Z; Shao J; Li Y
    Oncotarget; 2017 Jun; 8(23):37594-37604. PubMed ID: 28410239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytotoxicity of homoharringtonine on leukemic stem-like cells in AML cell line KG-1].
    Shen JP; Yang H; Ni WM; Qian WB
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):485-90. PubMed ID: 23086639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.
    Chen R; Guo L; Chen Y; Jiang Y; Wierda WG; Plunkett W
    Blood; 2011 Jan; 117(1):156-64. PubMed ID: 20971952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homoharringtonine induces apoptosis and growth arrest in human myeloma cells.
    Lou YJ; Qian WB; Jin J
    Leuk Lymphoma; 2007 Jul; 48(7):1400-6. PubMed ID: 17613769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines.
    Meng HT; Li L; Liu H; Wang Y; Li GC; Qian WB
    Acta Pharmacol Sin; 2009 Nov; 30(11):1529-36. PubMed ID: 19820719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of homoharringtonine, a cytotoxic component of the evergreen plant Cephalotaxus harringtonia.
    Ni D; Ho DH; Vijjeswarapu M; Felix E; Rhea PR; Newman RA
    J Exp Ther Oncol; 2003; 3(1):47-52. PubMed ID: 12724858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis.
    Zhang J; Chen B; Wu T; Wang Q; Zhuang L; Zhu C; Fan N; Qing W; Ma Y; Xu X
    PLoS One; 2015; 10(11):e0142422. PubMed ID: 26544558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homoharringtonine and omacetaxine for myeloid hematological malignancies.
    Lü S; Wang J
    J Hematol Oncol; 2014 Jan; 7():2. PubMed ID: 24387717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells.
    Mai WY; Lin MF
    Chin Med J (Engl); 2005 Mar; 118(6):487-92. PubMed ID: 15788130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
    Tong H; Ren Y; Zhang F; Jin J
    Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin.
    Kuroda J; Kamitsuji Y; Kimura S; Ashihara E; Kawata E; Nakagawa Y; Takeuichi M; Murotani Y; Yokota A; Tanaka R; Andreeff M; Taniwaki M; Maekawa T
    Int J Hematol; 2008 Jun; 87(5):507-515. PubMed ID: 18415656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-xL is a dominant antiapoptotic protein that inhibits homoharringtonine-induced apoptosis in leukemia cells.
    Yin S; Wang R; Zhou F; Zhang H; Jing Y
    Mol Pharmacol; 2011 Jun; 79(6):1072-83. PubMed ID: 21415308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homoharringtonine suppresses LoVo cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways.
    Shi X; Zhu M; Gong Z; Yang T; Yu R; Wang J; Zhang Y
    Food Chem Toxicol; 2020 Feb; 136():110960. PubMed ID: 31726078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homoharringtonine: an effective new natural product in cancer chemotherapy.
    Zhou DC; Zittoun R; Marie JP
    Bull Cancer; 1995 Dec; 82(12):987-95. PubMed ID: 8745664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative proteomic study of Homoharringtonine-induced apoptosis in leukemia K562 cells.
    Zhou X; Xu N; Li R; Xiao Y; Gao G; Lu Q; Ding L; Li L; Li Y; Du Q; Liu X
    Leuk Lymphoma; 2015 Jul; 56(7):2162-9. PubMed ID: 25330443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.